Issue 3/2020
Content (17 Articles)
The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer
Akshay J. Patel, Alex Richter, Mark T. Drayson, Gary W. Middleton
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
Brooke E. Wilson, Bertrand Routy, Adnan Nagrial, Venessa T. Chin
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
Simer J. Bains, Hanna Abrahamsson, Kjersti Flatmark, Svein Dueland, Knut H. Hole, Therese Seierstad, Kathrine Røe Redalen, Sebastian Meltzer, Anne Hansen Ree
Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
Junxun Ma, Danyang Sun, Jinliang Wang, Chun Han, Yuanyu Qian, Guangying Chen, Xiaoyan Li, Juan Zhang, Pengfei Cui, Wushuang Du, Zhaozhen Wu, Shixue Chen, Xuan Zheng, Zhichao Yue, Jia Song, Chan Gao, Shangli Cai, Yi Hu
Lung cancer-derived extracellular vesicles: a possible mediator of mast cell activation in the tumor microenvironment
Pazit Salamon, Yoseph A. Mekori, Irit Shefler
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, Madi R. Madiyalakan, Yolanda D. Mahnke, Christopher Nicodemus
Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study
Guowei Zhang, Ruirui Cheng, Huijuan Wang, Yong Zhang, Xiangtao Yan, Peng Li, Mina Zhang, Xiaojuan Zhang, Jinpo Yang, Yuanyuan Niu, Zhiyong Ma
Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas
Mikael Roussel, Faustine Lhomme, Caroline E. Roe, Todd Bartkowiak, Pauline Gravelle, Camille Laurent, Thierry Fest, Jonathan M. Irish
The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide
Subhashis Sarkar, Sachin K. S. Chauhan, John Daly, Alessandro Natoni, Heather Fairfield, Robert Henderson, Emma Nolan, Dawn Swan, Jinsong Hu, Michaela R. Reagan, Michael O’Dwyer
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
Caroline Bergenfelz, Anna Roxå, Meliha Mehmeti, Karin Leandersson, Anna-Maria Larsson
Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
Remy Thomas, Hibah Shaath, Adviti Naik, Salman M. Toor, Eyad Elkord, Julie Decock
The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction
Hongzhi Quan, Zhongyan Shan, Ziyi Liu, Sixuan Liu, Liu Yang, Xiaodan Fang, Kun Li, Baisheng Wang, Zhiyuan Deng, Yanjia Hu, Zhigang Yao, Junhui Huang, Jianjun Yu, Kun Xia, Zhangui Tang, Liangjuan Fang
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
Steve Boudewijns, Martine Bloemendal, Nienke de Haas, Harm Westdorp, Kalijn F. Bol, Gerty Schreibelt, Erik H. J. G. Aarntzen, W. Joost Lesterhuis, Mark A. J. Gorris, Alexandra Croockewit, Lieke L. van der Woude, Michelle M. van Rossum, Marieke Welzen, Anna de Goede, Stanleyson V. Hato, Winette T. A. van der Graaf, Cornelis J. A. Punt, Rutger H. T. Koornstra, Winald R. Gerritsen, Carl G. Figdor, I. Jolanda M. de Vries
PD-L1 expression levels should be considered when identifying risk factors in NSCLC patients treated with nivolumab
Pengfei Li, Guowei Che
PCSK9 is a promising prognostic marker in patients with advanced NSCLC
Aldo Bonaventura, Francesco Grossi, Fabrizio Montecucco
Retraction Note to: Bio‑HMGB1 from breast cancer contributes to M‑MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC‑like cells
Zhaoliang Su, Ping Ni, Peng She, Yueqin Liu, Seidu A. Richard, Wenlin Xu, Haitao Zhu, Jia Wang